Sign in to continue:

Monday, February 23rd, 2026

Day: February 22, 2026

ADAMAS TRUST, INC. (Formerly New York Mortgage Trust, Inc.) 2025 Annual 10-K Report – Real Estate Investment Trust Financials, Equity Method Investments, and Mortgage Loan Portfolio Analysis

Adamas Trust, Inc. (Formerly New York Mortgage Trust, Inc.) Files 2025 Annual Report: Key Investor Highlights Company Overview and Structure Adamas Trust, Inc., formerly known as New York Mortgage Trust, Inc., is a Real...

Astera Labs, Inc. 2025 Annual Report: Business Overview, Risk Factors, and AI Connectivity Solutions for Cloud Infrastructure

Astera Labs 2025 Annual Report: Key Financial Highlights and Investor Insights Astera Labs 2025 Annual Report: Key Financial Highlights and Investor Insights Astera Labs, Inc. (Nasdaq: ALAB) has released its Annual Report on Form...

Omnicom 2025 Annual Report: Business Overview, AI Integration, Risk Factors, and Cybersecurity Strategy

Omnicom Group Inc. Annual Report 2025: Investor Analysis Omnicom Group Inc. Annual Report 2025: Key Updates, Risks, and Investor Implications Executive Summary Omnicom Group Inc., a leading global marketing and communications company, has released...

Fantasia Holdings Announces Approval of Offshore Debt Restructuring Schemes and Upcoming Court Hearings

Fantasia Holdings Group Co., Limited Announces Key Milestone in Offshore Debt Restructuring: Approval of Schemes by Creditors Summary of Key Developments Fantasia Holdings Group Co., Limited (HKEX: 1777) has secured crucial creditor approval for...

Xuanzhu Biopharm Added to Hang Seng Composite Index, Boosting Sihuan Pharmaceutical’s Innovative Drug Profile 123

Sihuan Pharmaceutical Holdings Group Ltd. – Xuanzhu Biopharm Included in Hang Seng Composite Index Sihuan Pharmaceutical Holdings Group Ltd.: Xuanzhu Biopharm Added to Hang Seng Composite Index Key Points for Investors Xuanzhu Biopharm Included...

Xuanzhu Biopharm Included in Hang Seng Composite Index, Enhancing Market Visibility and Investment Value

Xuanzhu Biopharmaceutical Co., Ltd. Added to Hang Seng Composite Index: What Investors Need to Know Key Highlights: Xuanzhu Biopharmaceutical Co., Ltd. (“Xuanzhu Biopharm”, Stock Code: 2575) has been officially included as a constituent of...

Tianli International Holdings Director Increases Shareholding and Announces On-Market Share Repurchase

Tianli International Holdings: Director Share Purchase and On-Market Share Repurchase Tianli International Holdings Announces Director Share Purchase and On-Market Share Repurchase Tianli International Holdings Limited (Stock Code: 1773) has issued a voluntary announcement detailing...

Sanergy Group Limited Completes Placing of 228 Million New Shares, Raises HK$18.4 Million for Graphite Electrodes and Corporate Purposes 12

Sanergy Group Limited Completes Placing of New Shares Under General Mandate Sanergy Group Limited Announces Completion of New Share Placement, Raising HK\$18.4 Million for Business Expansion and Liquidity Key Highlights Sanergy Group Limited (Stock...

Yixin Group Limited Announces Board Meeting for 2025 Annual Results and Dividend Consideration

Key Highlights for Investors Board Meeting Scheduled: Yixin Group Limited has announced that its Board of Directors will convene on Thursday, March 5, 2026. The central agenda of this meeting is to consider and...

Huazhang Technology Issues Profit Warning: Expected Increased Loss for Six Months Ended December 2025 Due to Project Delays

Huazhang Technology Issues Profit Warning for H2 2025 Huazhang Technology Holding Limited Issues Significant Profit Warning for Second Half of 2025 Key Highlights and Details for Investors Significant Increase in Expected Losses: Huazhang Technology...